Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) October 25 – 27, 2024!

For more Information and Register: Delaware ACC By the Sea: 2024 Chapter Meeting

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

PURE Study: Social and Environmental Factors, Key Health Policy Recommendations
With accelerating urbanization in low- and middle-income countries contributing to significant environmental and societal impacts on cardiovascular health, a State of the Art Review published April 22...
Guest Editorial | A Message From the ACC President: Advancing Science, Research and Innovation
At the ACC, our commitment to science, research and innovation has never been stronger. As we navigate the current dynamic environment, we reaffirm our dedication to protecting and advancing the critical role of scientific discovery, especially at academic institutions and medical centers where so much of today's research in the fight against cardiovascular disease occurs.
New ACC/AHA Performance and Quality Measures Address Chronic Coronary Disease
With chronic coronary disease (CCD) the leading cause of death in the U.S., new clinical performance and quality measures released by the ACC and the American Heart Association offer practical steps for managing patient care that are aligned with the latest evidence-based CCD guidelines.
FDA Update: Agency Approves TAVR Valves For Asymptomatic Severe AS
The U.S. Food and Drug Administration (FDA) has approved the Sapien 3, Sapien 3 Ultra and Sapien 3 Ultra Resilia TAVR valves from Edwards Lifesciences to treat patients with asymptomatic severe aortic stenosis (AS).
Guest Editorial | ACC.25: Where Science, Connection and Joy Came to Life
ACC.25 is one for the books. Over three unforgettable days in Chicago, the Annual Scientific Session brought together the very best of cardiovascular science, education and community in ways that were more interactive, joyful and energizing than ever before.